Geographic and interseasonal heterogeneity of pharyngeal group A streptococcal (GAS) genotypes (emm types) is poorly characterized. We evaluated emm type and subtype distribution among pediatric pharyngitis isolates obtained from 9 sites in the United States during 2000-2001 (year 1) and from 10 sites in the United States and 1 site in Canada during 2001-2002 (year 2). The 7 predominant types were the same in both years, although their order changed. emm 12, 1, and 28 accounted for 49.2% of year 1 isolates, and emm 1, 12, and 4 accounted for 47.1% of year 2 isolates; 6 types accounted for 72.1% in year 1 and 69.4% in year 2. From year 1 to year 2, the proportions of emm 12 and 28 decreased and emm 1 and 6 increased. Striking intersite and interseasonal variations in the distribution of predominant emm types were observed. We conclude that the most-predominant GAS genotypes were similar for each year despite fluctuations, that intersite and intrasite variations in the distribution of emm types were apparent, and that emm type surveillance is needed as M protein vaccine development proceeds.
Since the development of group A streptococcal (GAS) M typing by Swift et al. in 1943 [1] , several studies have evaluated the distribution of various M types among clinical isolates. In 1957, Quinn et al. [2] studied hemolytic streptococci in school children, and HopeSimpson [3] characterized pharyngeal Streptococcus pyogenes in Gloucestershire, United Kingdom, from 1962 Kingdom, from through 1975 . These studies demonstrated the predominance of certain M and T typable strains (notably, M1, 6, 12, and 28 and T3, 4, and 12). Stollerman [4] reported that 81% of M-typable acute pharyngitis isolates at Children's Memorial Hospital (CMH; Chicago, IL) from 1956 through 1961 were M types 12, 6, 1, 5, and 3, with 18 other types accounting for the remaining Mtypable organisms. These early studies were hampered by a limited array of typing sera; many isolates were nontypeable. Molecular genotyping of emm genes encoding the type-specific portion of M proteins has led to identification of an increasing number of emm types, with 1160 distinct emm genotypes now identified [5, 6] . We and others have shown that many types cocirculate within communities [7] [8] [9] . Immunity to GAS strains is predominantly M type-specific, mediated by opsonophagocytic antibody to the hypervariable 35-50 amino terminal residues of M protein [10] .
The serotype distribution of invasive GAS strains is well characterized [11, 12] , but there has not been systematic acquisition and characterization of recent pediatric pharyngeal isolates from representative sites in the United States. Progress in M protein-based vaccine development highlights the importance of assessing the distribution of pharyngeal GAS types and the extent of geographic and temporal variation in their distribution [13, 14] . In addition, there has not been analysis of the variation within the serotype-specific M protein domains of pharyngeal GAS strains. We report our characterization of pediatric pharyngeal GAS isolates collected prospectively and systematically at North American sites during 2000-2001 and 2001-2002 . Isolates were genotyped and subtyped, and their emm type distribution was compared with the recent Active Bacterial Core surveillance collection of invasive GAS isolates [12] .
METHODS

Subjects and specimens.
We established the US Streptococcal Pharyngitis Surveillance Group at 9 diverse pediatric sites dur- (table 1) . All sites were primary care offices except the California site, which is a laboratory that services linked offices, and the Montreal site, which is a children's hospital.
From a convenience sample of children aged 3-18 years with acute pharyngitis, we collected ∼1000 GAS isolates from 15 November 2000 to 15 May 2001 and ∼1000 GAS isolates from 1 December 2001 to 15 May 2002. Each site had 2-4 collection intervals each year. Swabs or streaked plates, identified only by the age and sex of the patient and the date of acquisition, were shipped overnight to the Infectious Diseases Laboratory at CMH. The CMH institutional review board considered this an exempt study, because specimens were obtained for routine care, results could not be traced to individuals, and data were not utilized for clinical management.
Confirmation of group A streptococci. Swab samples were plated promptly, and individual b-hemolytic colonies were subcultured and grouped (PathoDX) to confirm the presence of Lancefield group A organisms.
Genotyping of group A streptococci. Single colonies were incubated overnight at 35Њ C, and the lawn of streptococci was harvested and suspended. Aliquots were frozen at Ϫ70ЊC in a 50% glycerol/50% Mueller-Hinton solution. DNA extracts were prepared as follows: aliquots were heated at 70ЊC for 10 min, centrifuged, and pellets were incubated in 50 mL of 10 mmol/ L Tris and 1 mmol/L EDTA (pH, 8.0) with 2 mL hyaluronidase (45,000 U/mL) and 10 mL mutanolysin (3000 U/mL) for 30 min at 37ЊC, boiled for 10 min, and frozen at Ϫ30ЊC. DNA extracts were shipped to the Streptococcal Research Laboratory at the Centers for Disease Control and Prevention (CDC; Atlanta, GA).
emm Sequence typing. With use of established protocols [5] , isolates were emm sequenced. An emm sequence type shares 195% DNA sequence identity over a 160-bp 5 region, with single in-frame deletions and/or insertions of up to 7 codons or single-frame shifts affecting no more than 7 codons permissible [5] . Base changes within the 150-bp region encoding the predicted mature M protein N terminus relative to CDC type strains are assigned subtype designations (e.g., emm 3.4, with the reference strain emm 3.0). The majority of CDC reference strains for emm types 1-60 were originally obtained from R. Lancefield (Rockefeller University). Type and subtype sequences are available for downloading and search with the Basic Local Alignment Search Tool (Blast) online (at http: //www.cdc.gov/ncidod/biotech/strep/strepblast.htm). We deduced predicted signal sequence cleavage sites using the tools on the Center for Biological Sequence Analysis Web site (http: //www.cbs.dtu.dk/services/SignalP/) exactly as instructed and using sequences trained on gram-positive bacteria. Most sequences examined included ∼700 bps; however, the data presented here focus on 150-base type-specific sequences encompassing approximately bases 67-216 of the emm amplicon.
Data analysis. Data were entered into an Excel spread sheet file (Microsoft). Descriptive statistics characterized age and sex of the subject from whom the sample was obtained. x 2 Analysis was performed for categorical variables. The relative proportions of the 10 most prevalent serotypes from each study site were assessed graphically to identify possible temporal and geographic trends.
An invasive index was calculated for each common emm type, defined as the proportion of invasive isolates in the 2000-2001 CDC surveillance collection [12] divided by the proportion of pharyngeal isolates obtained in 2000-2002 associated with that emm type in the present study.
RESULTS
In year 1, 1007 of 1070 specimens yielded GAS isolates. Eleven isolates from a tenth site were excluded because of the small number of isolates obtained from that site. Twenty-one isolates were lost. A total of 975 confirmed GAS isolates from 9 sites were characterized fully; 942 isolates from children 3-18 years 
942 (100) 1033 (100) old (range, 54-134 isolates per site; median, 111 isolates) (table 1) constituted the year 1 set; 52.4% of the isolates were obtained from male subjects. The mean age (‫ע‬SD) of the subjects was years. 8.1 ‫ע‬ 3.5
In year 2, 1076 of 1144 specimens from 11 sites yielded GAS isolates. Of these, 1054 of 1076 isolates were from children 3-18 years old (range, 50-115 isolates per site; median, 96 isolates). Twenty-one of these isolates were lost, and 1033 isolates were fully characterized as the year 2 set; 52.6% of the isolates were from male subjects. The mean age (‫ע‬SD) of the subjects was years. 7.8 ‫ע‬ 3.3 Isolate heterogeneity. emm Type distribution of study isolates is presented in table 2, with cumulative frequencies shown in figure 1. Overall, 29 emm types were recovered in year 1, including 2 new types (deletion variants of emm 12 and 1). Three types (emm 12, 1, and 28) accounted for 463 (49.2%) of 942 isolates, and these 3 types plus emm 4, 3, and 2 accounted for 679 (72.1%) of 942 isolates. The 10 most prevalent types accounted for 845 (89.7%) of 942 isolates. Nineteen other emm types-8 (including the 2 deletion variants) isolated once each-accounted for the remainder (table 2) .
In year 2, 31 emm types were identified (including 1 new type), with emm 1, 12, and 4 accounting for 487 (47.1%) of 1033 isolates; including emm 28, 3, and 2, the 6 most prevalent emm types accounted for 69.4% of the isolates. Ten types accounted for 85.9% of isolates, a proportion similar to that found in year 1; 21 other types, including 10 that were isolated once each, accounted for the remainder.
Only 1 isolate exhibited an emm gene defect predicted to result in a nonfunctional M protein: 1 of 2 emm 41.2 genes was predicted to encode a truncated M protein of 63 amino acids because of a 14-base insertion immediately after codon 54.
Year-to-year fluctuation in national proportions of the most common emm types was noted ( figure 1 and table 2 ). For example, from year 1 to year 2, emm 12 and 28 isolates decreased by 21% ( ) and 38% ( ), respectively, and P p .02 P ! .001 emm 1 and 6 increased by 44% and 17%, respectively (P ! for each). In addition, emm 75 isolates tripled in frequency .001 and displaced emm 22 as one of the 10 most frequently isolated types.
Geographic diversity. Intersite variation in degree of serotype diversity was evident, with the percentage of isolates accounted for by the 6 genotypes that were most prevalent nationally in year 1 ranging from 59.0% (in Illinois) to 81.5% (in Washington) at individual sites, and with the 10 genotypes that were most prevalent accounting for a percentage of isolates that ranged from 74.4% (in Illinois) to 98.1% (in Washington). Similarly, year 2 data show the percentage of isolates accounted for by the 7 most prevalent genotypes ranged from 56.5% (in Arkansas) to 88.2% (in Texas); the percentage of isolates accounted for by the 10 most prevalent genotypes ranged from 81.3% (in California and Quebec) to 97.1% (in Texas).
Geographic variability in distribution of individual emm types in year 1 and year 2 was apparent for each prevalent type (table 3) . For example, in year 1, the percentage of isolates accounted for by emm 12, the most common emm type nationally, ranged from 4.4% (in South Dakota) to 27.9% (in Arkansas); the same was true for other prevalent types. The same phenomenon was observed in year 2 (table 3); little cor- relation between study years is apparent. Figure 2 shows interyear variability of the most prevalent genotypes at 3 selected sites.
In addition, several less common genotypes in year 1 were maldistributed: 11 (50%) of 22 emm 44/61 isolates were from Illinois and 6 (27%) were from Texas; 4 (57%) of 7 emm 11 isolates were from California; 5 (71%) of 7 emm 82 isolates were from Connecticut; 2 (67%) of 3 emm 87 isolates were from Illinois; and 13 (72%) of 18 emm 75 isolates were from Illinois, Texas, and Arkansas. In year 2, 5 (45%) of 11 emm 118 isolates were from Pennsylvania and 3 were from Utah; 8 (40%) of 20 emm 44/61 strains were from Connecticut; 11 (25%) of 44 emm 89 isolates were from Pennsylvania; 6 (100%) of 6 emm 78 isolates were from Arkansas; and 2 (50%) of 4 emm 94 isolates were from California.
Subtypes. The array of subtypes based on sequences encoding amino acids 1-50 relative to CDC reference strains (i.e., reference sequences designated as emm 1.0, etc.) is presented in figure 3 (online only). Remarkably, emm 4.3 was the only 150-base subtype sequence differing from the CDC reference type solely by a synonymous substitution; all other nucleotide substitutions resulted in amino acid substitutions. In year 1, study isolates of 10 emm types displayed no differences within residues 1-50 or type-specific region variants, compared with CDC reference strains, including emm 2, 22, 28, 4 In marked contrast, no sequence identical to the M3 Lancefield reference strain emm sequence was found among 155 emm 3 study isolates. Almost all year 1 emm 3 isolates represented subtypes emm 3.1 (54 isolates), emm 3.4 (11 isolates), and emm 3.2 (5 isolates), and most year 2 emm 3 isolates were emm 3.1 (54 isolates), emm 3.4 (13 isolates), and emm 3.12 (8 isolates).
The CDC has accumulated a large database of emm gene sequences, primarily from invasive GAS isolates (available at http://www.cdc.gov/ncidod/biotech/strep/strepindex.htm), NOTE. The invasive index is calculated by dividing the percentage of invasive isolates by the percentage of pharyngitis isolates. Note that the invasive index is calculated from the pharyngitis data in the present study (representing 10 widely scattered North American sites, each of which contributed approximately equal numbers of isolates) and from the invasive isolate data from the 9 states comprising the Active Bacterial Core surveillance sites (in which more populous states contribute proportionally more isolates).
a Data presented are for study year 1 and year 2, as reported in the present study. b Data presented are for isolates reported in [12] .
particularly from Active Bacterial Core surveillance (available at http://www.cdc.gov/abcs). Subtypes found both among pharyngeal isolates in the present study and among 1061 invasive isolates obtained during 1999 and 2000 [12] are shown in figure  3 (online only); 39 of 63 variant subtypes shown in this figure were initially discovered during this pharyngitis surveillance. Geographic associations of several variant subtypes were noteworthy; for example, 17 of 21 emm 89.1 isolates were from Arkansas, 9 of 10 year 2 emm 6.7 isolates were from Utah, 8 of 8 emm 6.8 isolates were from South Dakota, 5 of 5 year 1 emm 3.2 isolates were from Connecticut, and 4 of 4 year 2 emm 6.9 isolates were from Texas.
Except for emm 5 and emm 6 (accounting for 14 and 50 year 1 isolates, respectively, and 15 and 64 year 2 isolates, respectively), emm types associated with у4 isolates were characterized primarily by a single 50-codon type-specific sequence. Type emm 5 exhibited 5 subtypes in year 1 and 6 subtypes (including emm 5.0) in year 2; much emm 5 variation results from homologous excisions of tandem repeats such that the 3 boundary of the hypervariable type-specific region is altered [12] (data not shown). Similarly, emm 6 exhibited 8 subtypes in year 1 and 9 subtypes in year 2.
New types. Three new emm types (stIL103, stIL62, and stPA57), from Illinois and Pennsylvania, were identified. Type stIL103 is very similar to emm 1, differing by a single intragenic deletion of 54 base pairs, resulting in deletion of M1 residues 7-24 and changing M1 Leu25 to isoleucine (figure 3; online only). Similarly, stIL62 differs from type emm 12 by a 42-base deletion within the type-specific sequence, leading to deletion of 14 codons. Type stPA57 was truly unique; it was most similar to emm 5 subtypes, but it had only ∼50%-60% amino acid sequence identity (figure 3; online only).
Sex and age. No sex differences in genotype distribution were apparent. However, age was related to the distribution of several genotypes, as described elsewhere [15] .
Invasive index. Table 4 shows the invasive index for 17 prevalent GAS genotypes, calculated from the relative proportion of pharyngeal isolates (reported in the present study) and invasive isolates for each genotype [12] . Certain emm types are less commonly associated with invasive disease than with pharyngitis (emm 2, 4, 6, 12, and 44/61), and others are more frequently associated with invasive infections (emm 3, 11, 73, 82, and 114). Of note, emm 1, the single most common invasive genotype, accounts for virtually identical proportions of invasive and pharyngeal isolates, with an invasive index of 0.96.
DISCUSSION
In this study, we identified features of pharyngeal GAS isolates with implications for streptococcal vaccine development. Relatively few emm types accounted for the majority of isolates at geographically diverse surveillance sites. The 10 most prevalent genotypes accounted for 86%-90% of isolates. However, during 2 respiratory seasons, 38 genotypes were identified, including 3 new genotypes. Three genotypes (emm 12, 1, and 28) represented 49% of isolates in year 1, and emm 1, 12, and 4 accounted for 47% of isolates in year 2. Six genotypes accounted for 72% of isolates in year 1 and 69% in year 2. That the surveillance site with the least heterogeneity during year 1 (South Dakota) yielded 10 emm types emphasizes the complex epidemiology of streptococcal pharyngitis. During year 2, lessstriking heterogeneity was observed, but all sites yielded у12 emm types. Considerable geographic variation in the prevalence of particular emm types was noted, with substantial site-to-site differences in prevalence of emm types. The epidemiologic complexity is highlighted further by an association between the age of subjects and the predominance of certain emm types [15] . In addition, intrasite differences in emm type distribution between study years were striking in some instances (figure 2). Year-to-year changes in genotypic prevalence at individual sites is consistent with the predominantly type-specific nature of immunity to group A streptococci, as was recently emphasized [16] .
Despite considerable geographic and temporal variation in emm type distribution, coverage by an effective multivalent Mprotein vaccine would be substantial. The 26-valent M-protein vaccine that is in clinical trials includes immunogens for 86% of pharyngeal isolates and a highly conserved epitope (streptococcal protective antigen) that may protect against additional types [13] . This vaccine includes 35-50 amino acid N-terminal segments of emm types 1-3, 5-6, 11-14, 18, 19, 22, 24, 28, 29 , 33, 43, 59, 75-77, 89, 92, 101, and 114. Of note, rabbits immunized with the 26-valent vaccine developed serum bactericidal activity against 5 of 7 randomly selected emm 4 isolates from the present study, even though M4 is not included in the vaccine [13] .
It is noteworthy that several classic rheumatogenic types, such as emm 5 and 18, were infrequent among acute-pharyngitis isolates in this study. emm 18 was isolated only 4 times, with no isolates from the Utah site, where acute rheumatic fever is common and thought to be related to mucoid emm 18 [17] . Recent data from Utah indicate that M18 strains became rare during 2001-2002, coinciding with year 2 of our surveillance [18] . emm 5 Isolates, also classically considered rheumatogenic, accounted for 1.5% of our isolates.
Most assessments of GAS type distribution focus on invasive or sterile site isolates [11, 19] . Studies evaluating emm type distribution among pharyngitis isolates generally are either limited in scope or limited geographically. A recent pharyngitis study at 8 US basic training sites indicated predominance of emm 29 (virtually all isolates of which were at 1 base), 3, 6, 44/61, 2, 75, and 1, with few emm 12 and 28 isolates [20] .
Comparison of our pharyngitis isolates to sterile site isolates obtained from 1995-1999 and from 2000-2001 yields findings of interest [11, 12] . Sterile site isolates are more heterogeneous, with the 3 most prevalent types (emm 1, 3, and 28) accounting for 37.5% of isolates (compared with 49% for pharyngitis isolates) and the 6 most prevalent accounting for 52.2% (compared with ∼70% for pharyngitis isolates). The 10 most prevalent types comprise ∼90% of pharyngitis isolates but only 64% [11] to 68.6% [12] of invasive isolates. There is considerable emm type overlap between pharyngitis and sterile-site isolates, with emm 1, 12, and 28 among the 4 most prevalent types for both. This reinforces the concept that children with pharyngitis are an important reservoir for GAS strains with invasive potential [7] . Nevertheless, interesting differences in the relative frequencies of certain emm types exist between pharyngitis and sterile-site isolates, as expressed by the invasive index (table 4) . Among the 12 most common types, emm 2, 4, 6, 44/61, and 12 each had a low invasive index value and accounted for smaller proportions of invasive isolates than did pharyngeal isolates; emm 1, 3, 5, 11, 73, 82, and 89 had higher invasive index values. Differences in virulence factors, including in exotoxins, may account for variations in invasiveness. When considering the invasive index values, it should be recognized that, although both surveillance systems were geographically diverse, the specific geographic areas and the sampling methods differed. This possibly could influence the observed differences in invasive index values, but it seems unlikely that it could change the findings substantially.
Although much heterogeneity has been observed among the 1160 emm sequence types, the present study demonstrates remarkable sequence conservation within most of the common types. Most of these recent isolates (i.e., those within emm types 1-89) share identical M type-specific sequences with corresponding reference strains that were isolated 20-70 years ago [5, 6, 21] . M subtype variation is relatively minor ( figure 3 ; online only). Because M protein is subject to selective pressure by host immune responses, undefined structural restrictions on variation of the type-specific region must exist. Our study is unique in that we present data on large numbers of pharyngitis isolates that were systematically acquired from geographically diverse pediatric sites (including all US regions and 1 Canadian city), that were collected throughout the streptococcal season, and that were all emm typed [11] . The results demonstrate that, despite considerable emm type heterogeneity, the majority of pharyngitis isolates are concentrated within relatively few M serotypes. An effective M protein-based vaccine encompassing the most prevalent serotypes may impact very substantially on streptococcal pharyngitis and its complications.
THE US STREPTOCOCCAL PHARYNGITIS SURVEILLANCE GROUP
